A new era for cancer target therapies: Applying systems biology and computer-aided drug design to cancer therapies

Yung Hao Wong, Chia Chiun Chiu, Chih Lung Lin, Ting Shou Chen, Bo Ren Jheng, Yu Ching Lee, Jeremy Chen, Bor Sen Chen

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

In recent years, many systems biology approaches have been used with various cancers. The materials described here can be used to build bases to discover novel cancer therapy targets in connection with computer-aided drug design (CADD). A deeper understanding of the mechanisms of cancer will provide more choices and correct strategies in the development of multiple target drug therapies, which is quite different from the traditional cancer single target therapy. Targeted therapy is one of the most powerful strategies against cancer and can also be applied to other diseases. Due to the large amount of progress in computer hardware and the theories of computational chemistry and physics, CADD has been the main strategy for developing novel drugs for cancer therapy. In contrast to traditional single target therapies, in this review we will emphasize the future direction of the field, i.e., multiple target therapies. Structure-based and ligand-based drug designs are the two main topics of CADD. The former needs both 3D protein structures and ligand structures, while the latter only needs ligand structures. Ordinarily it is estimated to take more than 14 years and 800 million dollars to develop a new drug. Many new CADD software programs and techniques have been developed in recent decades. We conclude with an example where we combined and applied systems biology and CADD to the core networks of four cancers and successfully developed a novel cocktail for drug therapy that treats multiple targets.

Original languageEnglish
Pages (from-to)1246-1267
Number of pages22
JournalCurrent Pharmaceutical Biotechnology
Volume17
Issue number14
DOIs
Publication statusPublished - Nov 1 2016

Fingerprint

Computer-Aided Design
Systems Biology
Drug Design
Neoplasms
Ligands
Drug Therapy
Therapeutics
Physics
Software
Pharmaceutical Preparations

Keywords

  • Carcinogenesis
  • Carcinogenesis relevance value
  • Computer-aided drug design
  • Multiple target cocktail
  • Network markers
  • Protein-protein interactions

ASJC Scopus subject areas

  • Biotechnology
  • Pharmaceutical Science

Cite this

A new era for cancer target therapies : Applying systems biology and computer-aided drug design to cancer therapies. / Wong, Yung Hao; Chiu, Chia Chiun; Lin, Chih Lung; Chen, Ting Shou; Jheng, Bo Ren; Lee, Yu Ching; Chen, Jeremy; Chen, Bor Sen.

In: Current Pharmaceutical Biotechnology, Vol. 17, No. 14, 01.11.2016, p. 1246-1267.

Research output: Contribution to journalReview article

Wong, Yung Hao ; Chiu, Chia Chiun ; Lin, Chih Lung ; Chen, Ting Shou ; Jheng, Bo Ren ; Lee, Yu Ching ; Chen, Jeremy ; Chen, Bor Sen. / A new era for cancer target therapies : Applying systems biology and computer-aided drug design to cancer therapies. In: Current Pharmaceutical Biotechnology. 2016 ; Vol. 17, No. 14. pp. 1246-1267.
@article{855651c3412e4badacfb1ccb14064d46,
title = "A new era for cancer target therapies: Applying systems biology and computer-aided drug design to cancer therapies",
abstract = "In recent years, many systems biology approaches have been used with various cancers. The materials described here can be used to build bases to discover novel cancer therapy targets in connection with computer-aided drug design (CADD). A deeper understanding of the mechanisms of cancer will provide more choices and correct strategies in the development of multiple target drug therapies, which is quite different from the traditional cancer single target therapy. Targeted therapy is one of the most powerful strategies against cancer and can also be applied to other diseases. Due to the large amount of progress in computer hardware and the theories of computational chemistry and physics, CADD has been the main strategy for developing novel drugs for cancer therapy. In contrast to traditional single target therapies, in this review we will emphasize the future direction of the field, i.e., multiple target therapies. Structure-based and ligand-based drug designs are the two main topics of CADD. The former needs both 3D protein structures and ligand structures, while the latter only needs ligand structures. Ordinarily it is estimated to take more than 14 years and 800 million dollars to develop a new drug. Many new CADD software programs and techniques have been developed in recent decades. We conclude with an example where we combined and applied systems biology and CADD to the core networks of four cancers and successfully developed a novel cocktail for drug therapy that treats multiple targets.",
keywords = "Carcinogenesis, Carcinogenesis relevance value, Computer-aided drug design, Multiple target cocktail, Network markers, Protein-protein interactions",
author = "Wong, {Yung Hao} and Chiu, {Chia Chiun} and Lin, {Chih Lung} and Chen, {Ting Shou} and Jheng, {Bo Ren} and Lee, {Yu Ching} and Jeremy Chen and Chen, {Bor Sen}",
year = "2016",
month = "11",
day = "1",
doi = "10.2174/13892010176661610191606",
language = "English",
volume = "17",
pages = "1246--1267",
journal = "Current Pharmaceutical Biotechnology",
issn = "1389-2010",
publisher = "Bentham Science Publishers B.V.",
number = "14",

}

TY - JOUR

T1 - A new era for cancer target therapies

T2 - Applying systems biology and computer-aided drug design to cancer therapies

AU - Wong, Yung Hao

AU - Chiu, Chia Chiun

AU - Lin, Chih Lung

AU - Chen, Ting Shou

AU - Jheng, Bo Ren

AU - Lee, Yu Ching

AU - Chen, Jeremy

AU - Chen, Bor Sen

PY - 2016/11/1

Y1 - 2016/11/1

N2 - In recent years, many systems biology approaches have been used with various cancers. The materials described here can be used to build bases to discover novel cancer therapy targets in connection with computer-aided drug design (CADD). A deeper understanding of the mechanisms of cancer will provide more choices and correct strategies in the development of multiple target drug therapies, which is quite different from the traditional cancer single target therapy. Targeted therapy is one of the most powerful strategies against cancer and can also be applied to other diseases. Due to the large amount of progress in computer hardware and the theories of computational chemistry and physics, CADD has been the main strategy for developing novel drugs for cancer therapy. In contrast to traditional single target therapies, in this review we will emphasize the future direction of the field, i.e., multiple target therapies. Structure-based and ligand-based drug designs are the two main topics of CADD. The former needs both 3D protein structures and ligand structures, while the latter only needs ligand structures. Ordinarily it is estimated to take more than 14 years and 800 million dollars to develop a new drug. Many new CADD software programs and techniques have been developed in recent decades. We conclude with an example where we combined and applied systems biology and CADD to the core networks of four cancers and successfully developed a novel cocktail for drug therapy that treats multiple targets.

AB - In recent years, many systems biology approaches have been used with various cancers. The materials described here can be used to build bases to discover novel cancer therapy targets in connection with computer-aided drug design (CADD). A deeper understanding of the mechanisms of cancer will provide more choices and correct strategies in the development of multiple target drug therapies, which is quite different from the traditional cancer single target therapy. Targeted therapy is one of the most powerful strategies against cancer and can also be applied to other diseases. Due to the large amount of progress in computer hardware and the theories of computational chemistry and physics, CADD has been the main strategy for developing novel drugs for cancer therapy. In contrast to traditional single target therapies, in this review we will emphasize the future direction of the field, i.e., multiple target therapies. Structure-based and ligand-based drug designs are the two main topics of CADD. The former needs both 3D protein structures and ligand structures, while the latter only needs ligand structures. Ordinarily it is estimated to take more than 14 years and 800 million dollars to develop a new drug. Many new CADD software programs and techniques have been developed in recent decades. We conclude with an example where we combined and applied systems biology and CADD to the core networks of four cancers and successfully developed a novel cocktail for drug therapy that treats multiple targets.

KW - Carcinogenesis

KW - Carcinogenesis relevance value

KW - Computer-aided drug design

KW - Multiple target cocktail

KW - Network markers

KW - Protein-protein interactions

UR - http://www.scopus.com/inward/record.url?scp=84995938496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995938496&partnerID=8YFLogxK

U2 - 10.2174/13892010176661610191606

DO - 10.2174/13892010176661610191606

M3 - Review article

C2 - 27774890

AN - SCOPUS:84995938496

VL - 17

SP - 1246

EP - 1267

JO - Current Pharmaceutical Biotechnology

JF - Current Pharmaceutical Biotechnology

SN - 1389-2010

IS - 14

ER -